MedTrace Logo

Mindfulness-informed Intervention for Improving Diabetes Outcomes in Type 2 Diabetes

NCT07130370 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-08-26

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if Acceptance and Commitment Therapy (ACT), a mindfulness-based psychological approach, can improve health and emotional well-being in adults with type 2 diabetes.

The main questions it aims to answer are:

Can ACT reduce diabetes-related distress?

Can ACT improve self-care behaviors?

Can ACT improve psychological flexibility?

Researchers will compare people who receive ACT to those in a waitlist control group to see if ACT has better effects on diabetes-related outcomes.

Participants will:

Attend ACT sessions tailored for people with type 2 diabetes

Complete questionnaires about their health, mood, and self-care.

Conditions

  • Type 2 Diabetes (T2DM)

Interventions

BEHAVIORAL

Acceptance and commitment therapy

Acceptance and Commitment Therapy (ACT) is a mindfulness-informed behavioral intervention that helps individuals accept difficult thoughts and feelings, clarify personal values, and commit to meaningful actions. It aims to improve psychological flexibility, enabling healthier coping with life's challenges.

Sponsors & Collaborators

  • National University of Modern Languages

    lead OTHER

Principal Investigators

  • Anila Sadaf, PhD · National University of Modern Languages, Islamabad

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-01
Primary Completion
2025-07-15
Completion
2025-07-15

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07130370 on ClinicalTrials.gov